Full Text Full Text (PDF) CME: Take the course for this article: Schizophrenia Citation Map Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via Google Scholar Articles by Kane, J. M. Search for Related Content Articles by Kane, J. M.

New-Onset Schizophrenia: Pharmacologic Treatment

Correspondence: Address Correspondence to: John M. Kane, M.D., Chairman, Department of Psychiatry, The Zucker Hillside Hospital, 75-59 263 St., Glen Oaks, NY 11004.

The management of new-onset schizophrenia represents an enormous challenge and opportunity. The evaluation and treatment decisions that are implemented at this phase of illness can have an important impact on subsequent course and outcome. It is important to consider factors that are specific to managing first-episode patients when choosing medication, establishing a treatment plan, and evaluating both therapeutic response and potential adverse reactions. Maintenance treatment strategies and approaches to facilitating adherence with clinical recommendations are also important issues in this context.

Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us